Related Experiment Videos
The effectiveness of diphenhydramine HCI in pediatric sleep disorders
Insights
Diphenhydramine elixir is a safe and effective sleep aid for children. This study found it significantly reduced sleep latency and nighttime awakenings compared to placebo.
Area of Science:
- Pediatric Sleep Medicine
- Clinical Pharmacology
Background:
- Sleep disorders are common in children, impacting their health and development.
- Effective and safe interventions are needed to manage pediatric sleep disturbances.
Purpose of the Study:
- To evaluate the efficacy and safety of diphenhydramine elixir as a bedtime sleep aid in children.
- To compare diphenhydramine's effects against a placebo in a pediatric population.
Main Methods:
- A placebo-controlled, double-blind clinical trial involving 50 children with various sleep disorders.
- Diphenhydramine elixir administered at 1.0 mg/kg at bedtime, with sleep parameters monitored by parents.
- Weekly global assessments of sleep disturbance severity and therapeutic effects.
Main Results:
- Diphenhydramine significantly reduced sleep latency and the number of nighttime awakenings compared to placebo.
- A marginal increase in total sleep duration was observed with diphenhydramine.
- No significant differences were found for restlessness, nightmares, or difficulty awakening between groups.
Conclusions:
- Diphenhydramine elixir demonstrates significant efficacy in improving key sleep parameters for pediatric patients.
- The study supports diphenhydramine as a safe and effective option for managing childhood sleep disturbances.
- Further research may explore long-term effects and optimal dosing for specific pediatric sleep conditions.
Abstract:
Fifty children with a variety of sleep disorders were studied in a placebo-controlled, double-blind clinical trial of diphenydramine elixir given in a dosage of 1.0 mg/kg at bedtime. Sleep records measuring latency time, number of awakenings, and duration of sleep were compiled by the patient's parent. A global assessment as to the severity of sleep disturbance and the therapeutic effect of the medication and placebo was made on a weekly basis. Diphenhydramine was significantly better than placebo in reducing sleep latency time and the number of awakenings per night, while sleep duration was marginally increased. There were no essential differences between diphenhydramine and placebo in the other study parameters, i.e., restlessness, nightmares, and difficulty awakening. Diphenhydramine was judged to be more effective than placebo on the weekly global assessment. The results indicate that diphenhydramine is a safe, effective bedtime sleep aid for pediatric patients.